These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36721699)

  • 1. Deleted in liver cancer 1 suppresses the growth of prostate cancer cells through inhibiting Rho-associated protein kinase pathway.
    Gong H; Chen K; Zhou L; Jin Y; Chen W
    Asian J Urol; 2023 Jan; 10(1):50-57. PubMed ID: 36721699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
    Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
    PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
    Tripathi V; Popescu NC; Zimonjic DB
    Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
    Guan M; Tripathi V; Zhou X; Popescu NC
    Cancer Gene Ther; 2008 Jun; 15(6):371-81. PubMed ID: 18369381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions.
    Tripathi V; Popescu NC; Zimonjic DB
    Springerplus; 2014; 3():27. PubMed ID: 24683532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
    Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
    J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor protein DLC1 maintains protein kinase D activity and Golgi secretory function.
    Jensch A; Frey Y; Bitschar K; Weber P; Schmid S; Hausser A; Olayioye MA; Radde NE
    J Biol Chem; 2018 Sep; 293(37):14407-14416. PubMed ID: 30045871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.
    Zhou X; Yang XY; Popescu NC
    Biochem Biophys Res Commun; 2012 Apr; 420(2):325-30. PubMed ID: 22425986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLC1 negatively regulates angiogenesis in a paracrine fashion.
    Shih YP; Liao YC; Lin Y; Lo SH
    Cancer Res; 2010 Nov; 70(21):8270-5. PubMed ID: 20861185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis.
    Wang Y; Lei R; Zhuang X; Zhang N; Pan H; Li G; Hu J; Pan X; Tao Q; Fu D; Xiao J; Chin YE; Kang Y; Yang Q; Hu G
    J Clin Invest; 2014 Apr; 124(4):1646-59. PubMed ID: 24590291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLC1 as a regulator of proliferation, invasion, cell cycle, and apoptosis in cutaneous squamous cell carcinoma.
    Yang C; Wu D; Jia J; Liu D; Li Z; Zhang C; Li M; Xia Y
    Tumour Biol; 2013 Oct; 34(5):2633-43. PubMed ID: 23625658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.
    Yang XY; Guan M; Vigil D; Der CJ; Lowy DR; Popescu NC
    Oncogene; 2009 Mar; 28(11):1401-9. PubMed ID: 19151751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells.
    Shih YP; Takada Y; Lo SH
    Mol Cancer Res; 2012 Jan; 10(1):34-9. PubMed ID: 22064653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
    Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
    Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
    Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
    Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
    Ullmannova V; Popescu NC
    Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.